Characterization of a novel gelatin-binding 21 kDa protein secreted by cultured adherent cells.
A novel gelatin-binding 21 kDa protein was identified in the culture medium of fibroblastic and sarcoma cells by affinity chromatography on gelatin-Sepharose. Its affinity for gelatin was lower than that of the other gelatin-binding proteins, fibronectin and the 70 kDa protein, as judged by stepwise elution by urea and arginine. The protein bound also to spermine and to some extent to heparin but not to staphylococcal protein A, bovine serum albumin, concanavalin A or plain Sepharose 4B. In gel filtration chromatography the protein eluted in fractions differing from those of fibronectin and the Mr 70,000 protein and retained its ability to bind to gelatin-Sepharose, indicating that the binding was not mediated by the two other gelatin-binding proteins. It contains intrachain disulfide bridges, as judged by analysis under nonreducing and reducing conditions. The protein is composed of two major subtypes with pI values of 5.85-6.10 and 6.55-6.75. It was sensitive to trypsin but not to collagenase or thrombin. Antiserum was raised in rabbits against the gelatin-binding proteins isolated from serum-free conditioned fibroblast culture medium. The antiserum reacted with fibronectin, the Mr 70,000 protein and the Mr 21,000 protein in immunoprecipitation experiments. Absorption of the antiserum with human plasma fibronectin did not decrease its reactivity with the Mr 70,000 and 21,000 proteins. However, absorption with the Mr 70,000 protein abolished also the reactivity against the Mr 21,000 protein, suggesting immunological cross-reactivity. The protein was synthesized independently from the Mr 70,000 protein, as shown by pulse-chase labeling experiments of cells. The production of the Mr 21,000 protein in cultured cells was enhanced by transforming growth factor-beta.
D002352:Carrier Proteins / Q000032:analysis*; D002448:Cell Adhesion; D002460:Cell Line; D002478:Cells, Cultured; D002846:Chromatography, Affinity; D003429:Cross Reactions; D004220:Disulfides / Q000032:analysis; D005347:Fibroblasts / Q000032:analysis; D005353:Fibronectins / Q000378:metabolism; D006493:Heparin / Q000378:metabolism; D006801:Humans; D007163:Immunosorbent Techniques; D003012:Microbial Collagenase / Q000378:metabolism; D008970:Molecular Weight; D010455:Peptides / Q000494:pharmacology; D012509:Sarcoma / Q000032:analysis; D012709:Serum Albumin / Q000378:metabolism; D013096:Spermine / Q000378:metabolism; D013205:Staphylococcal Protein A / Q000378:metabolism; D013917:Thrombin / Q000378:metabolism; D015291:Transforming Growth Factors; D014357:Trypsin / Q000378:metabolism
D002352:Carrier Proteins; D004220:Disulfides; D005353:Fibronectins; D010455:Peptides; D012709:Serum Albumin; D013205:Staphylococcal Protein A; C033135:gelatin binding protein; D013096:Spermine; D015291:Transforming Growth Factors; D006493:Heparin; D014357:Trypsin; D013917:Thrombin; D003012:Microbial Collagenase